Tag: designation
TME Pharma: FDA Grants Fast Track Designation for NOX-A12
(Boursier.com) — TME Pharmaa biotechnology company specializing in the development of new therapies for the treatment of cancer by targeting the tumor microenvironment (TME), announces that the US Food and…
TME Pharma: Fast Track designation in glioblastoma – 04/03/2024 at 1:27 p.m.
(CercleFinance.com) – TME Pharma announces that the US FDA has granted Fast Track designation to its NOX-A12, in combination with radiotherapy and bevacizumab, for use in the treatment of aggressive…
TME PHARMA – The US FDA grants Fast Track designation for NOX-A12, TME Pharma’s lead program, in brain cancer – 04/02/2024 at 8:30 p.m.
TME Pharma NV (Euronext Growth Paris: ALTME), a biotechnology company specializing in the development of novel therapies for the treatment of cancer by targeting the tumor microenvironment (TME), announces that…
Johnson & Johnson: ‘Fast Track’ designation for nipocalimab
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Advicenne: ODD designation in cystinuria
(CercleFinance.com) – The biopharmaceutical company Advicenne announces that ADV7103, its proprietary drug, has obtained orphan drug status (ODD) from the US FDA for the treatment of cystinuria in the United…
GSK: Fast Track designation for an experimental vaccine
(CercleFinance.com) – GSK announced today that the United States Food and Drug Administration (FDA) has granted Fast Track designation to its investigational vaccine against Neisseria gonorrhoeae (NgG). The vaccine candidate…
Poxel: titer rises, orphan drug designation – 01/25/2023 at 11:30 am
(CercleFinance.com) – Poxel stock recorded one of the strongest rises in the CAC Mid & Small index on Wednesday after obtaining orphan drug designation from the European Commission for the…
AB Science: ODS designation for masitinib in Switzerland – 12/28/2022 at 08:45
(CercleFinance.com) – AB Science announces that its masitinib has received orphan drug designation (ODS) from the Swiss Institute for Therapeutic Products (Swissmedic) for the treatment of patients with amyotrophic lateral…
AB Science: masitinib received orphan drug designation in Switzerland – 28/12/2022 at 09:33
(AOF) – AB Science SA announces that masitinib has received orphan drug designation (ODS) from the Swiss Institute for Therapeutic Products (Swissmedic) for the treatment of patients with amyotrophic lateral…
AB Science: Masitinib Receives Orphan Drug Designation for the Treatment of ALS in Switzerland
By Alexandra Saintpierre Published on 27/12/2022 at 7:59 p.m. Photo credit © AB Science …
Advicenne obtains orphan drug designation for ADV7103, in the United States – 12/13/2022 at 08:50
(AOF) – Advicenne has announced that ADV7103, its proprietary drug in phase III in the United States, has been granted orphan drug status for the treatment of distal renal tubular…
Court in Zurich protects animal designation for meat substitutes
The Zurich administrative court judges the labeling of meat substitute products more pragmatically than the cantonal laboratory. A look at the production of meat substitutes from pea protein by Planted…